Episode Details

210 - Private Markets for Everyone, Grail's FDA Win & the Rise of Consumer AI Agents

Episode 210 Published 4 weeks ago

Description

In this episode, Marcus and Vic bring the headlines back: why 10-year Treasury yields at their highest level since 2002 signal a fiscal problem healthcare can't ignore, how Trump's agenda has pushed up rates and inflation, Neko Health's $700M bet on whole-body scanning and Precision Neuroscience's $250M Series D, the GLOBE rule's shrinking Medicare savings, the SEC opening private markets to ordinary investors, HHS's push to redesign clinical trials, Cigna's AI-driven savings, UPMC's acquisition of Trinity Health, Epic's pause to focus on cybersecurity, the FDA panel backing Grail's Galleri test, the FTC's probe of OpenAI and Anthropic, and the arrival of consumer AI agents like OpenAI's Dots with insights into market trends, policy changes, and technological innovations shaping the future of health and money.

Chapters

0:00 Introduction

2:20 August PCE inflation reading ↳

https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-09-30-2026/card/what-to-know-about-today-s-pce-index-YnU6yGlmCpHowo8u4TSP

3:16 US bond yields hit their highest level since 2002 ↳

https://www.nytimes.com/2026/10/01/business/bond-yields-10-year-treasury.html

7:28 How Trump's economic moves drove rates and inflation higher ↳

https://www.wsj.com/economy/trump-economy-inflation-jobs-724e4da8

10:15 Neko Health's $700M bet on whole-body scanning ↳

https://techcrunch.com/podcast/the-investor-behind-neko-healths-700m-bet-on-scanning-your-whole-body/

12:54 Precision Neuroscience's $250M Series D for brain-computer interfaces ↳

https://www.fiercebiotech.com/medtech/precision-neuroscience-taps-250m-series-d-funding-brain-computer-interface